These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19763327)

  • 1. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
    Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
    Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of structural determinants of ligand selectivity in 5-HT₂ receptor subtypes on the basis of protein-ligand interactions.
    Jang JW; Kim MS; Cho YS; Cho AE; Pae AN
    J Mol Graph Model; 2012 Sep; 38():342-53. PubMed ID: 23085173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluation.
    Miller KJ; Wu GY; Varnes JG; Levesque P; Li J; Li D; Robl JA; Rossi KA; Wacker DA
    Mol Pharmacol; 2009 Dec; 76(6):1211-9. PubMed ID: 19767451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the roles of serines 5.43(239) and 5.46(242) for binding and potency of agonist ligands at the human serotonin 5-HT2A receptor.
    Braden MR; Nichols DE
    Mol Pharmacol; 2007 Nov; 72(5):1200-9. PubMed ID: 17715398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor.
    Łukasiewicz S; Faron-Górecka A; Kędracka-Krok S; Dziedzicka-Wasylewska M
    Eur J Pharmacol; 2011 Jun; 659(2-3):114-23. PubMed ID: 21496455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.
    Braden MR; Parrish JC; Naylor JC; Nichols DE
    Mol Pharmacol; 2006 Dec; 70(6):1956-64. PubMed ID: 17000863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
    Xie J; Dernovici S; Ribeiro P
    J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.
    Li Y; Huang XF; Deng C; Meyer B; Wu A; Yu Y; Ying W; Yang GY; Yenari MA; Wang Q
    Synapse; 2010 Mar; 64(3):224-30. PubMed ID: 19862688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.
    Bonaventure P; Nepomuceno D; Miller K; Chen J; Kuei C; Kamme F; Tran DT; Lovenberg TW; Liu C
    Eur J Pharmacol; 2005 Apr; 513(3):181-92. PubMed ID: 15862800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.
    Hazai E; Joshi P; Skoviak EC; Suryanarayanan A; Schulte MK; Bikadi Z
    Bioorg Med Chem; 2009 Aug; 17(16):5796-805. PubMed ID: 19640719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based identification of aporphines with selective 5-HT(2A) receptor-binding activity.
    Munusamy V; Yap BK; Buckle MJ; Doughty SW; Chung LY
    Chem Biol Drug Des; 2013 Feb; 81(2):250-6. PubMed ID: 23039820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype.
    Bruno A; Beato C; Costantino G
    Future Med Chem; 2011 Apr; 3(6):665-81. PubMed ID: 21554074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.
    Lewgowd W; Bojarski AJ; Szczesio M; Olczak A; Glowka ML; Mordalski S; Stanczak A
    Eur J Med Chem; 2011 Aug; 46(8):3348-61. PubMed ID: 21601317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants for the interaction of the valvulopathic anorexigen norfenfluramine with the 5-HT2B receptor.
    Setola V; Dukat M; Glennon RA; Roth BL
    Mol Pharmacol; 2005 Jul; 68(1):20-33. PubMed ID: 15831837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes.
    Derangeon M; Bozon V; Defamie N; Peineau N; Bourmeyster N; Sarrouilhe D; Argibay JA; Hervé JC
    J Mol Cell Cardiol; 2010 Jan; 48(1):220-9. PubMed ID: 19615378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for cis-urocanic acid as a 5-HT(2A) receptor agonist.
    Shen L; Ji HF
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5307-9. PubMed ID: 19683920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "salt-bridge disruption" mechanism.
    Kristiansen K; Kroeze WK; Willins DL; Gelber EI; Savage JE; Glennon RA; Roth BL
    J Pharmacol Exp Ther; 2000 Jun; 293(3):735-46. PubMed ID: 10869371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists.
    Wang CD; Buck MA; Fraser CM
    Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.